Long-term efficacy of pembrolizumab (pembro; MK-3475) in a pooled analysis of 655 patients (pts) with advanced melanoma (MEL) enrolled in KEYNOTE-001

Adil Daud, Antoni Ribas, Caroline Robert, F. Stephen Hodi, Jedd D. Wolchok, Anthony M. Joshua, Wen-Jen Hwu, Jeffrey S. Weber, Tara C. Gangadhar, Richard Wayne Joseph, Roxana Stefania Dronca, Amita Patnaik, Hassane M. Zarour, Richard Kefford, Jill Ann Lindia, Xiaoyun Nicole Li, Scot Ebbinghaus, Soonmo Peter Kang, Omid Hamid

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)9005
Number of pages1
JournalJournal of Clinical Oncology
Issue number15 supplement
Publication statusPublished - 20 May 2015
Externally publishedYes
EventAnnual Meeting of the American Society of Clinical Oncology (ASCO) - Chicago, United States
Duration: 31 May 20134 Jun 2013

Cite this